
Misook Yu
Supervisory Patent Examiner (ID: 13848, Phone: (571)272-0839 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1641 |
| Total Applications | 878 |
| Issued Applications | 268 |
| Pending Applications | 204 |
| Abandoned Applications | 408 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5348773
[patent_doc_number] => 20090004134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF AN ERP57 PROTEIN TO A CELLULAR MEMBRANE'
[patent_app_type] => utility
[patent_app_number] => 11/845065
[patent_app_country] => US
[patent_app_date] => 2007-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 13400
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004134.pdf
[firstpage_image] =>[orig_patent_app_number] => 11845065
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/845065 | KIT FOR TREATING A HEALTH CONDITION BY INDUCING TRANSLOCATION OF AN ERP57 PROTEIN TO A CELLULAR MEMBRANE | Aug 24, 2007 | Abandoned |
Array
(
[id] => 4939587
[patent_doc_number] => 20080076906
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-03-27
[patent_title] => 'Antagonists of neuropilin receptor function and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/893413
[patent_app_country] => US
[patent_app_date] => 2007-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 17393
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0076/20080076906.pdf
[firstpage_image] =>[orig_patent_app_number] => 11893413
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/893413 | Antagonists of neuropilin receptor function and use thereof | Aug 15, 2007 | Abandoned |
Array
(
[id] => 4570658
[patent_doc_number] => 07824678
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-11-02
[patent_title] => 'Antibodies against cancer antigen TMEFF2 and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/837337
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16481
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/824/07824678.pdf
[firstpage_image] =>[orig_patent_app_number] => 11837337
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/837337 | Antibodies against cancer antigen TMEFF2 and uses thereof | Aug 9, 2007 | Issued |
Array
(
[id] => 4903977
[patent_doc_number] => 20080113390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Personalized assay for the identification of an effective therapy for cancer'
[patent_app_type] => utility
[patent_app_number] => 11/891315
[patent_app_country] => US
[patent_app_date] => 2007-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2690
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20080113390.pdf
[firstpage_image] =>[orig_patent_app_number] => 11891315
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/891315 | Personalized assay for the identification of an effective therapy for cancer | Aug 7, 2007 | Abandoned |
Array
(
[id] => 4823002
[patent_doc_number] => 20080227701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 11/829778
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10690
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227701.pdf
[firstpage_image] =>[orig_patent_app_number] => 11829778
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/829778 | ANTIANGIOGENIC POLYPEPTIDES AND METHODS FOR INHIBITING ANGIOGENESIS | Jul 26, 2007 | Abandoned |
Array
(
[id] => 4669358
[patent_doc_number] => 20080044418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Tumor Antigens and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/782310
[patent_app_country] => US
[patent_app_date] => 2007-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 28607
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20080044418.pdf
[firstpage_image] =>[orig_patent_app_number] => 11782310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/782310 | Tumor Antigens and Uses Thereof | Jul 23, 2007 | Abandoned |
Array
(
[id] => 4682784
[patent_doc_number] => 20080249010
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Method Of Inducing Apoptosis In Lymphoid Cells'
[patent_app_type] => utility
[patent_app_number] => 11/761942
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8937
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249010.pdf
[firstpage_image] =>[orig_patent_app_number] => 11761942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/761942 | Method Of Inducing Apoptosis In Lymphoid Cells | Jun 11, 2007 | Abandoned |
Array
(
[id] => 190923
[patent_doc_number] => 07642234
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-01-05
[patent_title] => 'Beta-2-glycoprotein 1 is an inhibitor of angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 11/810521
[patent_app_country] => US
[patent_app_date] => 2007-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 20
[patent_no_of_words] => 31297
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/642/07642234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11810521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/810521 | Beta-2-glycoprotein 1 is an inhibitor of angiogenesis | Jun 4, 2007 | Issued |
Array
(
[id] => 5354705
[patent_doc_number] => 20090186049
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-23
[patent_title] => 'METHOD OF TREATING MAGE POSITIVE CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/301541
[patent_app_country] => US
[patent_app_date] => 2007-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 8485
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0186/20090186049.pdf
[firstpage_image] =>[orig_patent_app_number] => 12301541
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/301541 | METHOD OF TREATING MAGE POSITIVE CANCER | May 23, 2007 | Abandoned |
Array
(
[id] => 5091687
[patent_doc_number] => 20070231326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-04
[patent_title] => 'Immunological Methods of Treating Cancer'
[patent_app_type] => utility
[patent_app_number] => 11/804182
[patent_app_country] => US
[patent_app_date] => 2007-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21923
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0231/20070231326.pdf
[firstpage_image] =>[orig_patent_app_number] => 11804182
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/804182 | Immunological Methods of Treating Cancer | May 16, 2007 | Abandoned |
Array
(
[id] => 5258737
[patent_doc_number] => 20070212369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Colon Specific Genes and Proteins'
[patent_app_type] => utility
[patent_app_number] => 11/748211
[patent_app_country] => US
[patent_app_date] => 2007-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16867
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11748211
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/748211 | Colon Specific Genes and Proteins | May 13, 2007 | Abandoned |
Array
(
[id] => 5348741
[patent_doc_number] => 20090004102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease'
[patent_app_type] => utility
[patent_app_number] => 11/801415
[patent_app_country] => US
[patent_app_date] => 2007-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 49724
[patent_no_of_claims] => 108
[patent_no_of_ind_claims] => 26
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0004/20090004102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11801415
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/801415 | HSC70 directed diagnostics and therapeutics for multidrug resistant neoplastic disease | May 8, 2007 | Abandoned |
Array
(
[id] => 5259107
[patent_doc_number] => 20070212739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-13
[patent_title] => 'Novel cancer-associated antigens and methods of their identification and use'
[patent_app_type] => utility
[patent_app_number] => 11/799584
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14800
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0212/20070212739.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799584
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799584 | Cancer-associated antigens and methods of their identification and use | May 1, 2007 | Issued |
Array
(
[id] => 5085824
[patent_doc_number] => 20070275875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Method for preventing colon cancer'
[patent_app_type] => utility
[patent_app_number] => 11/799578
[patent_app_country] => US
[patent_app_date] => 2007-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6242
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20070275875.pdf
[firstpage_image] =>[orig_patent_app_number] => 11799578
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/799578 | Method for preventing colon cancer | May 1, 2007 | Abandoned |
Array
(
[id] => 4910435
[patent_doc_number] => 20080021202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'NOVEL APOPTOSIS PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 11/739267
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22708
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20080021202.pdf
[firstpage_image] =>[orig_patent_app_number] => 11739267
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/739267 | Apoptosis proteins | Apr 23, 2007 | Issued |
Array
(
[id] => 4797872
[patent_doc_number] => 20080009458
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-10
[patent_title] => 'COP1 molecules and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/786399
[patent_app_country] => US
[patent_app_date] => 2007-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 21933
[patent_no_of_claims] => 112
[patent_no_of_ind_claims] => 73
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20080009458.pdf
[firstpage_image] =>[orig_patent_app_number] => 11786399
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/786399 | COP1 molecules and uses thereof | Apr 9, 2007 | Issued |
Array
(
[id] => 4688135
[patent_doc_number] => 20080032316
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'TUMOR ASSOCIATED ANTIGENS AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 11/697639
[patent_app_country] => US
[patent_app_date] => 2007-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14569
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0032/20080032316.pdf
[firstpage_image] =>[orig_patent_app_number] => 11697639
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/697639 | TUMOR ASSOCIATED ANTIGENS AND METHODS OF USING THE SAME | Apr 5, 2007 | Abandoned |
Array
(
[id] => 4833338
[patent_doc_number] => 20080131885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Biomarkers for cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 11/732362
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 46
[patent_no_of_words] => 15355
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131885.pdf
[firstpage_image] =>[orig_patent_app_number] => 11732362
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/732362 | Biomarkers for cancer treatment | Apr 1, 2007 | Issued |
Array
(
[id] => 4977279
[patent_doc_number] => 20070218512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'METHODS RELATED TO MMP26 STATUS AS A DIAGNOSTIC AND PROGNOSTIC TOOL IN CANCER MANAGEMENT'
[patent_app_type] => utility
[patent_app_number] => 11/680396
[patent_app_country] => US
[patent_app_date] => 2007-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19927
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0218/20070218512.pdf
[firstpage_image] =>[orig_patent_app_number] => 11680396
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/680396 | METHODS RELATED TO MMP26 STATUS AS A DIAGNOSTIC AND PROGNOSTIC TOOL IN CANCER MANAGEMENT | Feb 27, 2007 | Abandoned |
Array
(
[id] => 173544
[patent_doc_number] => 07658923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26'
[patent_app_type] => utility
[patent_app_number] => 11/676164
[patent_app_country] => US
[patent_app_date] => 2007-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 31336
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/658/07658923.pdf
[firstpage_image] =>[orig_patent_app_number] => 11676164
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/676164 | Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 | Feb 15, 2007 | Issued |